View in EDS

Inhibition of the ZEB1-BCL2 axis in cancer-associated fibroblasts as a strategy to improve chemotherapy response in intrahepatic cholangiocarcinoma.

Saved in:
Bibliographic Details
Title: Inhibition of the ZEB1-BCL2 axis in cancer-associated fibroblasts as a strategy to improve chemotherapy response in intrahepatic cholangiocarcinoma.
Authors: Gonzalez-Sanchez E; HepatoBiliary Tumours Lab, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, CSIC-Universidad de Salamanca, Salamanca 37007, Spain; Department of Physiology and Pharmacology, University of Salamanca, Salamanca 37007, Spain; National Biomedical Research Institute on Liver and Gastrointestinal Diseases (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain., Vallette M; Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, Paris F-75012, France., Garcia-Collado L; HepatoBiliary Tumours Lab, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, CSIC-Universidad de Salamanca, Salamanca 37007, Spain., Ravichandra A; TUM School of Medicine and Health, Department of Clinical Medicine - Clinical Department for Internal Medicine II, University Medical Center, Technical University of Munich, Germany., Minini M; Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, Paris F-75012, France; Université Paris Cité, CNRS, Inserm, NABI, Paris F-75006, France., Pavy A; Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, Paris F-75012, France., Amengual J; TGF-β and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Roldán-Hernández CA; HepatoBiliary Tumours Lab, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, CSIC-Universidad de Salamanca, Salamanca 37007, Spain., Ramirez AM; HepatoBiliary Tumours Lab, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, CSIC-Universidad de Salamanca, Salamanca 37007, Spain., Louis C; Inserm, Univ Rennes, OSS (Oncogenesis, Stress, Signaling) UMR_S 1242, Centre de Lutte contre le Cancer Eugène Marquis, Rennes F-35042, France., Lozano JJ; Bioinformatic Platform, CIBERehd, Barcelona, Spain., Fabregat I; National Biomedical Research Institute on Liver and Gastrointestinal Diseases (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain; TGF-β and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Guedj N; Service d'Anatomie Pathologique Hôpital Beaujon, Clichy F-92110, France; INSERM, UMR 1149, Centre de Recherche sur l'Inflammation, Paris F-75018, France., Paradis V; Service d'Anatomie Pathologique Hôpital Beaujon, Clichy F-92110, France; INSERM, UMR 1149, Centre de Recherche sur l'Inflammation, Paris F-75018, France., Coulouarn C; Inserm, Univ Rennes, OSS (Oncogenesis, Stress, Signaling) UMR_S 1242, Centre de Lutte contre le Cancer Eugène Marquis, Rennes F-35042, France., Aoudjehane L; ICAN BioCell-Human Liver Biology core, IHU - Foundation for innovation in Cardiometabolism and Nutrition (IHU-ICAN), Paris F-75013, France; Sorbonne Université, INSERM, UMRS 1166, Paris F-75013, France., Fouassier L; Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, Paris F-75012, France; Université Paris Cité, CNRS, Inserm, NABI, Paris F-75006, France. Electronic address: laura.fouassier@inserm.fr., Vaquero J; HepatoBiliary Tumours Lab, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, CSIC-Universidad de Salamanca, Salamanca 37007, Spain; National Biomedical Research Institute on Liver and Gastrointestinal Diseases (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: javier.vaquero@usal.es.
Source: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2026 Aug; Vol. 201, pp. 119741. Date of Electronic Publication: 2026 Jul 06.
Publication Type: Journal Article
Journal Info: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1950-6007 (Electronic) Linking ISSN: 07533322 NLM ISO Abbreviation: Biomed Pharmacother Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42407325
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Inhibition of the ZEB1-BCL2 axis in cancer-associated fibroblasts as a strategy to improve chemotherapy response in intrahepatic cholangiocarcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gonzalez-Sanchez+E%22">Gonzalez-Sanchez E</searchLink>; HepatoBiliary Tumours Lab, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, CSIC-Universidad de Salamanca, Salamanca 37007, Spain; Department of Physiology and Pharmacology, University of Salamanca, Salamanca 37007, Spain; National Biomedical Research Institute on Liver and Gastrointestinal Diseases (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Vallette+M%22">Vallette M</searchLink>; Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, Paris F-75012, France.<br /><searchLink fieldCode="AU" term="%22Garcia-Collado+L%22">Garcia-Collado L</searchLink>; HepatoBiliary Tumours Lab, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, CSIC-Universidad de Salamanca, Salamanca 37007, Spain.<br /><searchLink fieldCode="AU" term="%22Ravichandra+A%22">Ravichandra A</searchLink>; TUM School of Medicine and Health, Department of Clinical Medicine - Clinical Department for Internal Medicine II, University Medical Center, Technical University of Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Minini+M%22">Minini M</searchLink>; Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, Paris F-75012, France; Université Paris Cité, CNRS, Inserm, NABI, Paris F-75006, France.<br /><searchLink fieldCode="AU" term="%22Pavy+A%22">Pavy A</searchLink>; Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, Paris F-75012, France.<br /><searchLink fieldCode="AU" term="%22Amengual+J%22">Amengual J</searchLink>; TGF-β and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Roldán-Hernández+CA%22">Roldán-Hernández CA</searchLink>; HepatoBiliary Tumours Lab, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, CSIC-Universidad de Salamanca, Salamanca 37007, Spain.<br /><searchLink fieldCode="AU" term="%22Ramirez+AM%22">Ramirez AM</searchLink>; HepatoBiliary Tumours Lab, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, CSIC-Universidad de Salamanca, Salamanca 37007, Spain.<br /><searchLink fieldCode="AU" term="%22Louis+C%22">Louis C</searchLink>; Inserm, Univ Rennes, OSS (Oncogenesis, Stress, Signaling) UMR_S 1242, Centre de Lutte contre le Cancer Eugène Marquis, Rennes F-35042, France.<br /><searchLink fieldCode="AU" term="%22Lozano+JJ%22">Lozano JJ</searchLink>; Bioinformatic Platform, CIBERehd, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Fabregat+I%22">Fabregat I</searchLink>; National Biomedical Research Institute on Liver and Gastrointestinal Diseases (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain; TGF-β and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Guedj+N%22">Guedj N</searchLink>; Service d'Anatomie Pathologique Hôpital Beaujon, Clichy F-92110, France; INSERM, UMR 1149, Centre de Recherche sur l'Inflammation, Paris F-75018, France.<br /><searchLink fieldCode="AU" term="%22Paradis+V%22">Paradis V</searchLink>; Service d'Anatomie Pathologique Hôpital Beaujon, Clichy F-92110, France; INSERM, UMR 1149, Centre de Recherche sur l'Inflammation, Paris F-75018, France.<br /><searchLink fieldCode="AU" term="%22Coulouarn+C%22">Coulouarn C</searchLink>; Inserm, Univ Rennes, OSS (Oncogenesis, Stress, Signaling) UMR_S 1242, Centre de Lutte contre le Cancer Eugène Marquis, Rennes F-35042, France.<br /><searchLink fieldCode="AU" term="%22Aoudjehane+L%22">Aoudjehane L</searchLink>; ICAN BioCell-Human Liver Biology core, IHU - Foundation for innovation in Cardiometabolism and Nutrition (IHU-ICAN), Paris F-75013, France; Sorbonne Université, INSERM, UMRS 1166, Paris F-75013, France.<br /><searchLink fieldCode="AU" term="%22Fouassier+L%22">Fouassier L</searchLink>; Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, Paris F-75012, France; Université Paris Cité, CNRS, Inserm, NABI, Paris F-75006, France. Electronic address: laura.fouassier@inserm.fr.<br /><searchLink fieldCode="AU" term="%22Vaquero+J%22">Vaquero J</searchLink>; HepatoBiliary Tumours Lab, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, CSIC-Universidad de Salamanca, Salamanca 37007, Spain; National Biomedical Research Institute on Liver and Gastrointestinal Diseases (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: javier.vaquero@usal.es.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228213295%22">Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie</searchLink> [Biomed Pharmacother] 2026 Aug; Vol. 201, pp. 119741. <i>Date of Electronic Publication: </i>2026 Jul 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Editions+Scientifiques+Elsevier%22">Editions Scientifiques Elsevier </searchLink><i>Country of Publication: </i>France <i>NLM ID: </i>8213295 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1950-6007 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2207533322%22">07533322 </searchLink><i>NLM ISO Abbreviation: </i>Biomed Pharmacother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42407325
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.biopha.2026.119741
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 119741
    Titles:
      – TitleFull: Inhibition of the ZEB1-BCL2 axis in cancer-associated fibroblasts as a strategy to improve chemotherapy response in intrahepatic cholangiocarcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gonzalez-Sanchez E
      – PersonEntity:
          Name:
            NameFull: Vallette M
      – PersonEntity:
          Name:
            NameFull: Garcia-Collado L
      – PersonEntity:
          Name:
            NameFull: Ravichandra A
      – PersonEntity:
          Name:
            NameFull: Minini M
      – PersonEntity:
          Name:
            NameFull: Pavy A
      – PersonEntity:
          Name:
            NameFull: Amengual J
      – PersonEntity:
          Name:
            NameFull: Roldán-Hernández CA
      – PersonEntity:
          Name:
            NameFull: Ramirez AM
      – PersonEntity:
          Name:
            NameFull: Louis C
      – PersonEntity:
          Name:
            NameFull: Lozano JJ
      – PersonEntity:
          Name:
            NameFull: Fabregat I
      – PersonEntity:
          Name:
            NameFull: Guedj N
      – PersonEntity:
          Name:
            NameFull: Paradis V
      – PersonEntity:
          Name:
            NameFull: Coulouarn C
      – PersonEntity:
          Name:
            NameFull: Aoudjehane L
      – PersonEntity:
          Name:
            NameFull: Fouassier L
      – PersonEntity:
          Name:
            NameFull: Vaquero J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2026 Aug
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1950-6007
          Numbering:
            – Type: volume
              Value: 201
          Titles:
            – TitleFull: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
              Type: main
ResultId 1